snapIoT Declares AI-Powered Automated IRB Packaging and UAT...
pharmatechoutlook

snapIoT Declares AI-Powered Automated IRB Packaging and UAT Reporting for Patient Engagement Solutions

By Pharma Tech Outlook | Friday, July 10, 2020

Jeremy Wyatt, CTO & Senior VP

A San Diego-based company, snapIoT Inc., announces Automated AI-powered IRB Packaging and UAT Reporting feature to congregate all patient-facing visual assets and expedite the submission process for IRB and ethics approvals. 

FREMONT, CA: Typically, this time-consuming process of IRB and ethics packaging is prone to human error and is performed manually at the end of app development stages. snapClinical™’s AI-powered Automated Documentation Engine formulates a critical patient-facing documentation asset for IRB Package setup and submission and also UAT Reporting. With a single click, an AI-powered automation engine will run the app, go through all screens and generate screenshots, traverse all protocol flows and collect forms of data and auto-generate the required materials within a single report. Annotations can be documented and exported to different file formats for further editing and processing. Pharma and CRO companies can now have a faster, more efficient, and reliable method to aid in launching digitally-enabled clinical trials.

“We have worked very closely with an early stage User Group comprised of many of the Top 10 Pharmaceutical and CRO companies as well as several IRB and Ethics SME’s to rapidly deploy this modern feature. Our Automated AI-powered IRB Packaging and UAT Reporting feature achieves the objectives of a better streamlined process to reduce time, costs and human error,” states CEO of snapIoT, Isaac Eteminan.

snapIoT is a San Diego-based company, and a market leader in decentralized mClinical trial innovation. Their mClinical platform, snapClinical, offers unlimited capabilities in developing and deploying patient-centric engagement solutions like eConsent, eCOA, Telemedicine, and various other patient engagement solutions to support decentralized trials. snapClinical functions as a SaaS/PaaS model to enable users to build self-service solutions on Android, iOS, and HTML5 via intuitive drag-and-drop platform, or as a full turnkey service. snapIoT was also featured in Pharma Tech Outlook as one of the Top 10 eClinical Trial Management Solution Providers.

Weekly Brief

Read Also